Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide and Cabergoline in Partially Responsive Acromegaly
NCT00376064Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cabergoline in acromegaly, sponsored by Novartis. Started Mar 2006; status: completed.
02
Drugs
cabergoline
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00376064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376064.